skip to content

Axis 2 / Subject 1: Financial mechanisms for improving access to MEGs

Presentations:
 

Financial mechanisms for improving access to MEGs

Speaker

Jacques PILLOY, former raw materials purchaser in a major pharmaceutical company; currently a member of the OTECI network.

General scheme of the Presentation
  • Illustration of the impact of an industrial approach to improving access to ACT.
  • The ARTEPAL project, financed by the European Union, has been developed in partnership with the AEDES Foundation and OTECI with the general goal of helping to increase global production of ACTs by intervening in the supply chain with the aim of adjusting supply to demand in terms of quantity, quality and price. One of the specific objectives has also been to encourage local production in Africa to the extent that that may be justified in technical and economic terms.
  • The various fields covered by the project are : (i) permanent analysis of the market, (ii) technical assistance to planters, extractors and technology transfer; (iii) technical assistance to ACT producers; (iv) information.
  • This project terminated in December 2009 after 5 years in existence and was the point of departure for overall thinking about a new financial mechanism (A2S2 - Assure Artemisinin Supply System) providing support in the form of loans to extractors (project financed by UNITAID), currently in operational phase (partnership between the AEDES Foundation, OTECI and I-Plus Solutions).
Essential questions on which the presentation is based
  • What lessons can be drawn from a mechanism of this type?
  • Is it applicable to other areas? Which for example?
 

Changes in financing mechanisms for medicines: the experience of community friendly societies in the Comoros Islands

Speaker

Jean-Louis MACHURON, pharmacist, Fondation Mérieux ; founder of the association « Pharmacie et Aide Humanitaire (PAH) ».

General scheme of the Presentation
  • Presentation of the experience of community friendly societies in the Comoros Islands (set up with support from CIDR).
  • Principles on which the friendly society is based.
  • Reflections on axes of change in financing medicines.
Essential questions on which the presentation is based
  • How can this type of financing mechanism (friendly societies) be supported and how can their coverage be extended?
  • How can MEG supply systems be adapted to developments in this type of financing?
 

Developments in financing mechanisms for medicines: Financing Based on Performance (« PBF »)

Speaker

Olivier BARTHÈS, public health doctor, AEDES cooperator, particular experience in Democratic Republic of the Congo (co ordinator of the Santé 98e FED project), where Health Services Purchasing Funds (FASS) have been set up with mechanisms linked to PBF principles.

General scheme of the Presentation
  • Presentation of financing principles based on performance (« PBF »)
  • PBF involvement in developments in the MEG market.
Essential questions on which the presentation is based
  • How can the mechanism be applied to medicines?
  • How can the MEG procurement system be adapted to developments in financing mechanisms and more particularly to this type of financing?